Entrada Therapeutics, Inc. - TRDA

SEC FilingsOur TRDA Tweets

About Gravity Analytica

Recent News

  • 06.09.2025 - 46th Annual Goldman Sachs Global Healthcare Conference
  • 06.09.2025 - 46th Annual Goldman Sachs Global Healthcare Conference
  • 06.04.2025 - Jefferies Global Healthcare Conference
  • 06.04.2025 - Jefferies Global Healthcare Conference
  • 06.04.2025 - Jefferies Global Healthcare Conference
  • 06.04.2025 - Jefferies Global Healthcare Conference
  • 06.03.2025 - Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
  • 06.03.2025 - Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
  • 06.02.2025 - Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 06.02.2025 - Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

  • 05.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]